02.12.2012 Views

NO - Besoin d'assistance

NO - Besoin d'assistance

NO - Besoin d'assistance

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Mechanisms and Biomarkers (WG 4) page 25<br />

__________________________________________________________________________________________<br />

changes usually occurring with more or less long delay. It should be emphasized that such<br />

biomarkers are very useful to investigate the interactions of diet components on antioxidant<br />

status in short-term experiments. Thus, based on assumptions that oxidised DNA and<br />

lipoproteins are respectively involved in cancer and cardiovascular diseases, measurement of<br />

oxidised DNA bases and level of peroxidised lipids in LDL were used as surrogate<br />

biomarkers for the latter diseases. The methods and the limits of these biomarkers were<br />

recently discussed by Halliwell (1999). Other parameters are now considered to evaluate<br />

antioxidant status. The latest investigations were designed to be used for human studies<br />

implying minimally invasive methods and focused mainly on products resulting from free<br />

radicals as biomarkers of free radical damage (De Zwart et al., 1999) and on the determination<br />

of plasma antioxidant capacity (Prior and Cao, 1999).<br />

Among the products resulting from free radical damage, the most representatives of lipid<br />

peroxidation products are exhaled pentanes, plasma and urine isoprostanes and aldehydic<br />

products. Hydroxylated DNA products (mainly Hydroxylated guanosine, 8-OH-dG) and<br />

carbonyls groups are the most usual markers for DNA and protein damage, respectively.<br />

More recently, a concept of antioxidant capacity has been developed and can be defined as an<br />

individual measure reflecting the sum of available endogenous and exogenous defence<br />

mechanisms which ensure the oxidative balance (Fürst, 1996). Measurement of antioxidant<br />

capacity is mostly developed in the plasma assuming as representative of in vivo whole-body<br />

antioxidants. Such a measurement avoids the measurement of each antioxidant separately and<br />

takes into account the possible interactions between them. The methodology consists on using<br />

a prooxidant, generally a free radical, and an oxidizable substrate. The prooxidant induces<br />

oxidative damage to the substrate which is inhibited by the antioxidants contained in the<br />

biological samples to be tested. In these inhibition methods many techniques were developed<br />

and the most usual one is oxygen radical absorbance capacity also known as ORAC assay<br />

(Cao et al., 1993). It uses phycoerythrin as oxidizable protein substrate and AAPH (an azo<br />

compound) as a peroxyl radical generator or copper-hydrogen peroxide as hydroxyl generator.<br />

Protein oxidation induced a quenching of fluorescence which is retarded by the antioxidants<br />

present in the tested samples. The quantitation is made by area-under-curve determination<br />

after completion of the reaction. A single value is thus determined for both inhibition<br />

percentage and length of inhibition time (the lag time during which the antioxidants from the<br />

sample protected oxidation of the protein). The ORAC assay has been used in several<br />

laboratories to determine the antioxidant of biological samples but also for pure compounds<br />

(melatonine, flavonoids) and complex matrices (tea, fruits and vegetables, and tissues). Other

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!